vs
Side-by-side financial comparison of AMERICAN BATTERY TECHNOLOGY Co (ABAT) and Cellectis S.A. (CLLS). Click either name above to swap in a different company.
Cellectis S.A. is the larger business by last-quarter revenue ($9.5M vs $4.8M, roughly 2.0× AMERICAN BATTERY TECHNOLOGY Co). AMERICAN BATTERY TECHNOLOGY Co runs the higher net margin — -195.0% vs -265.9%, a 70.9% gap on every dollar of revenue. On growth, AMERICAN BATTERY TECHNOLOGY Co posted the faster year-over-year revenue change (1331.8% vs 375.0%).
American Battery Technology Company, formerly American Battery Metals Corporation, is a US-based battery recycling technology startup founded in 2011. It employs a hydrometallurgical process to recycle batteries and a targeted extraction system to extract raw materials from primary resources.
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.
ABAT vs CLLS — Head-to-Head
Income Statement — Q2 FY2026 vs Q2 FY2024
| Metric | | |
|---|---|---|
| Revenue | $4.8M | $9.5M |
| Net Profit | $-9.3M | $-25.3M |
| Gross Margin | -33.6% | — |
| Operating Margin | -207.5% | -181.1% |
| Net Margin | -195.0% | -265.9% |
| Revenue YoY | 1331.8% | 375.0% |
| Net Profit YoY | 30.7% | -51.9% |
| EPS (diluted) | $-0.07 | $-0.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.8M | — | ||
| Q3 25 | $937.6K | — | ||
| Q2 25 | $2.8M | — | ||
| Q1 25 | $980.0K | — | ||
| Q2 24 | — | $9.5M | ||
| Q3 23 | — | $1.6M | ||
| Q2 23 | — | $2.0M | ||
| Q2 22 | — | $2.7M |
| Q4 25 | $-9.3M | — | ||
| Q3 25 | $-10.3M | — | ||
| Q2 25 | $-10.2M | — | ||
| Q1 25 | $-11.5M | — | ||
| Q2 24 | — | $-25.3M | ||
| Q3 23 | — | $-17.5M | ||
| Q2 23 | — | $-16.6M | ||
| Q2 22 | — | $-19.5M |
| Q4 25 | -33.6% | — | ||
| Q3 25 | -375.1% | — | ||
| Q2 25 | -92.6% | — | ||
| Q1 25 | -274.5% | — | ||
| Q2 24 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | 97.3% | ||
| Q2 22 | — | 87.9% |
| Q4 25 | -207.5% | — | ||
| Q3 25 | -1080.8% | — | ||
| Q2 25 | -280.1% | — | ||
| Q1 25 | -1086.3% | — | ||
| Q2 24 | — | -181.1% | ||
| Q3 23 | — | -1258.1% | ||
| Q2 23 | — | -1180.5% | ||
| Q2 22 | — | -1003.0% |
| Q4 25 | -195.0% | — | ||
| Q3 25 | -1098.5% | — | ||
| Q2 25 | -366.4% | — | ||
| Q1 25 | -1173.1% | — | ||
| Q2 24 | — | -265.9% | ||
| Q3 23 | — | -1064.1% | ||
| Q2 23 | — | -831.6% | ||
| Q2 22 | — | -714.4% |
| Q4 25 | $-0.07 | — | ||
| Q3 25 | $-0.09 | — | ||
| Q2 25 | $-0.09 | — | ||
| Q1 25 | $-0.14 | — | ||
| Q2 24 | — | $-0.28 | ||
| Q3 23 | — | $-0.31 | ||
| Q2 23 | — | $-0.20 | ||
| Q2 22 | — | $-0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $47.9M | $149.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $119.0M | $148.6M |
| Total Assets | $123.3M | $407.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $47.9M | — | ||
| Q3 25 | $30.9M | — | ||
| Q2 25 | $7.5M | — | ||
| Q1 25 | $7.8M | — | ||
| Q2 24 | — | $149.0M | ||
| Q3 23 | — | — | ||
| Q2 23 | — | $84.4M | ||
| Q2 22 | — | $129.4M |
| Q4 25 | $119.0M | — | ||
| Q3 25 | $96.0M | — | ||
| Q2 25 | $70.6M | — | ||
| Q1 25 | $65.6M | — | ||
| Q2 24 | — | $148.6M | ||
| Q3 23 | — | $76.1M | ||
| Q2 23 | — | $96.6M | ||
| Q2 22 | — | $180.5M |
| Q4 25 | $123.3M | — | ||
| Q3 25 | $101.5M | — | ||
| Q2 25 | $84.5M | — | ||
| Q1 25 | $76.5M | — | ||
| Q2 24 | — | $407.1M | ||
| Q3 23 | — | $209.7M | ||
| Q2 23 | — | $227.7M | ||
| Q2 22 | — | $320.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-9.8M | $28.9M |
| Free Cash FlowOCF − Capex | — | $27.6M |
| FCF MarginFCF / Revenue | — | 290.5% |
| Capex IntensityCapex / Revenue | — | 13.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-9.8M | — | ||
| Q3 25 | $-7.1M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-10.3M | — | ||
| Q2 24 | — | $28.9M | ||
| Q3 23 | — | — | ||
| Q2 23 | — | $-47.4M | ||
| Q2 22 | — | $-60.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | $27.6M | ||
| Q3 23 | — | — | ||
| Q2 23 | — | $-47.9M | ||
| Q2 22 | — | $-61.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | 290.5% | ||
| Q3 23 | — | — | ||
| Q2 23 | — | -2391.4% | ||
| Q2 22 | — | -2266.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | 13.2% | ||
| Q3 23 | — | — | ||
| Q2 23 | — | 24.1% | ||
| Q2 22 | — | 56.6% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
